Huilaja , L , Makikallio , K , Hannula-Jouppi , K , Vakeva , L , Hook-Nikanne , J & Tasanen , K 2015 , ' Cyclosporine Treatment in Severe Gestational Pemphigoid ' , Acta Dermato-Venereologica , vol. 95 , no. 5 , pp. 593-595 . https://doi.org/10.2340/00015555-2032
Julkaisun nimi: | Cyclosporine Treatment in Severe Gestational Pemphigoid |
Tekijä: | Huilaja, Laura; Makikallio, Kaarin; Hannula-Jouppi, Katariina; Vakeva, Liisa; Hook-Nikanne, Johanna; Tasanen, Kaisa |
Tekijän organisaatio: | Clinicum Department of Dermatology, Allergology and Venereology |
Päiväys: | 2015 |
Kieli: | eng |
Sivumäärä: | 3 |
Kuuluu julkaisusarjaan: | Acta Dermato-Venereologica |
ISSN: | 0001-5555 |
DOI-tunniste: | https://doi.org/10.2340/00015555-2032 |
URI: | http://hdl.handle.net/10138/161810 |
Tiivistelmä: | Gestational pemphigoid, a rare autoimmune skin disease typically occurring during pregnancy, is caused by autoantibodies against collagen XVII. Clinically it is characterised by severe itching followed by erythematous and bullous lesions of the skin. Topical or oral glucocorticoids usually relieve symptoms, but in more severe cases systemic immunosuppressive treatments are needed. Data on immunosuppressive medication controlling gestational pemphigoid are sparse. We report 3 intractable cases of gestational pemphigoid treated with cyclosporine. |
Avainsanat: |
pemphigoid gestationis
treatment cyclosporine LINKED-IMMUNOSORBENT-ASSAY PUSTULAR PSORIASIS PREGNANCY MANAGEMENT DERMATOSES DIAGNOSIS THERAPY ANTIGEN MILK 3121 General medicine, internal medicine and other clinical medicine |
Vertaisarvioitu: | Kyllä |
Pääsyrajoitteet: | openAccess |
Rinnakkaistallennettu versio: | publishedVersion |
Latausmäärä yhteensä: Ladataan...
Tiedosto(t) | Koko | Formaatti | Näytä |
---|---|---|---|
4334.pdf | 600.5KB | Avaa tiedosto |